Chimerix Inc (CMRX)
0.90
-0.01
(-1.50%)
USD |
NASDAQ |
Nov 22, 16:00
0.9068
+0.01
(+0.76%)
After-Hours: 20:00
Chimerix Cash from Financing (Quarterly): 0.178M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.178M |
| June 30, 2024 | -0.042M |
| March 31, 2024 | 0.208M |
| December 31, 2023 | 0.062M |
| September 30, 2023 | 0.078M |
| June 30, 2023 | -0.031M |
| March 31, 2023 | 0.199M |
| December 31, 2022 | -0.032M |
| September 30, 2022 | 0.778M |
| June 30, 2022 | -0.011M |
| March 31, 2022 | -13.46M |
| December 31, 2021 | 0.052M |
| September 30, 2021 | 0.557M |
| June 30, 2021 | 0.117M |
| March 31, 2021 | 111.70M |
| December 31, 2020 | 0.346M |
| September 30, 2020 | 0.26M |
| June 30, 2020 | 0.578M |
| March 31, 2020 | 0.229M |
| December 31, 2019 | 0.001M |
| September 30, 2019 | 0.166M |
| June 30, 2019 | 0.018M |
| March 31, 2019 | 0.16M |
| December 31, 2018 | 0.37M |
| September 30, 2018 | 10.62M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.055M |
| March 31, 2018 | 0.138M |
| December 31, 2017 | -0.054M |
| September 30, 2017 | 0.336M |
| June 30, 2017 | 0.102M |
| March 31, 2017 | 0.395M |
| December 31, 2016 | 0.016M |
| September 30, 2016 | 0.407M |
| June 30, 2016 | 0.019M |
| March 31, 2016 | 0.166M |
| December 31, 2015 | -0.511M |
| September 30, 2015 | -0.01M |
| June 30, 2015 | 161.17M |
| March 31, 2015 | 0.701M |
| December 31, 2014 | 115.11M |
| September 30, 2014 | 0.145M |
| June 30, 2014 | 110.70M |
| March 31, 2014 | -0.70M |
| December 31, 2013 | -0.061M |
| September 30, 2013 | -0.898M |
| June 30, 2013 | 107.79M |
| March 31, 2013 | -0.667M |
| December 31, 2012 | 0.005M |
| September 30, 2012 | 11.95M |
| June 30, 2012 | 0.002M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-13.46M
Minimum
Mar 2022
111.70M
Maximum
Mar 2021
5.088M
Average
0.1475M
Median
Cash from Financing (Quarterly) Benchmarks
| Abbott Laboratories | -1.576B |
| Emergent BioSolutions Inc | -180.30M |
| SIGA Technologies Inc | -0.2741M |
| Tonix Pharmaceuticals Holding Corp | 42.90M |
| Geovax Labs Inc | 16.35M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -20.51M |
| Cash from Investing (Quarterly) | 28.32M |
| Free Cash Flow | -70.42M |
| Free Cash Flow Per Share (Quarterly) | -0.2289 |
| Free Cash Flow to Equity (Quarterly) | -20.53M |
| Free Cash Flow Yield | -87.55% |